Drugs that are not approved by authorities like FDA and other federal authorities are considered unapproved drugs. FDA checks for the effectiveness and […]
The organ-on-chip technology is a customizable chip that has inbuilt facilities to enable the mimicking of the responses of organs or organ systems […]
Patient safety in clinical trials has become prominent in the priorities of clinical research organizations (CRO) and other sponsors. In lieu of this […]
Preclinical development processes for biopharmaceutical products refer to drug discovery, drug research and experimental testing on life forms other than humans that occur […]
Drug safety or pharmacovigilance, as it is formally termed, is the field of science that is responsible for assessing, identifying and recording the […]
According to the food and drug agency (FDA), sterile drug products are manufactured by two methods. They are terminal sterilization and aseptic processing. […]
When a patient/volunteer being administered a drug under clinical trials or outside trials in the case of a treatment regimen, undergoes an adverse […]
The term biosimilar refers to a pharmaceutical drug that is similar to an originally approved biological product with significant differences in safety and […]